Bulletin

Day Lewis secures £160m funds and targets 150 new pharmacies

Pharmacy - £160m funding facility to the Day Lewis Group - SantanderCB

A consortium of banks, including Santander, Lloyds Banking Group, RBS, HSBC and Barclays, has provided a £160m funding facility to the Day Lewis Group chemist chain. The support comes ahead of a targeted acquisition of 150 pharmacies by 2020 to add to its current portfolio of 277 sites. Day Lewis Group also said it aims to double its revenue, which was £264m in the year to the end of March 2015. The funding facility could even be extended to £210m. It will be used by Day Lewis Group to consolidate a number of sister firms as well as funding the acquisitions.

 

Note: News bulletin content has been provided by a third-party and is not the opinion of Santander

Other Articles

This International Women’s Day, our analysis reveals a continuing untapped potential and huge opportunity when it comes to women in…

London

London-based ACT Clean has secured private investor backing for a £10.2 million management buyout.

Bulletin
Spain

Santander takes 12 UK food and drink manufacturers to Spain on one of our successful trade missions. Adam Payne in the international team…

This International Women’s Day, our analysis reveals a continuing untapped potential and huge opportunity when it comes to women in…

London

London-based ACT Clean has secured private investor backing for a £10.2 million management buyout.

Bulletin
Getting a taste for Spain!

Santander takes 12 UK food and drink manufacturers to Spain on one of our Trade Missions. Alicia Ferrero Vega in the International team…

Bulletin

Where Next?